PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Lederle ×

UPDATED
Actualizaciones regulatorias
19 sept 2026•1 min de lectura
FDA NDA006920: Lederle's Triple Sulfas Oral Products Listed as Discontinued
The FDA’s NDA006920 for Lederle’s oral drug Triple Sulfas includes two discontinued formulations—a suspension and a tablet—both containing trisulfapyrimidines, sulfamerazine, and sulfamethazine.
UPDATED
Actualizaciones regulatorias
25 ago 2026•1 min de lectura
FDA Approves ANDA086746 for Amitriptyline Tablet – Lederle
FDA approved application ANDA086746 for an oral amitriptyline hydrochloride 25 mg tablet submitted by Lederle; the product is listed as discontinued.
1